|
|
Maroteaux-Lamy
|
|
Maroteaux-Lamy
[an error occurred while processing this directive]
The best day of my life! Sep 22, 2005
Oliver, from Drighlington, Leeds, suffers from the rare genetic condition mucopolysaccharidosis (MPS) VI, also known as Maroteaux-Lamy Syndrome. ...
- Leeds Today
Committee for Medicinal Products for Human Use Summary of Opinion ... Sep 16, 2005
...patients with a confirmed diagnosis of Mucopolysaccharidosis VI (MPS VI; Nacetylgalactosamine 4-sulphatase (galsulfase) deficiency; Maroteaux-Lamy syndrome) to ...
- PharmaLive.com (press release)
BioMarin Announces Positive Opinion for Naglazyme From European ... Sep 15, 2005
...for Naglazyme(TM) (galsulfase) an investigational enzyme replacement therapy for treatment of mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy syndrome). ...
- PR Newswire (press release)
BioMarin's Naglazyme gets positive opinion from CHMP for EU ... Sep 15, 2005
Products for Human Use (CHMP) recommending that the EU Commission grant marketing authorisation for Naglazyme, a therapy for Maroteaux-Lamy syndrome, a rare ...
- ForexTV.com
Health Alert: Enzyme deficiency Sep 9, 2005
...often die from that.". It's called maroteaux-lamy disease, after the two French doctors who first described it. Most cells in the ...
- WIS
BR boy first to get new drug treatment for rare genetic disorderJun 30, 2005
Nicholas and his brother, Luke, were diagnosed with Maroteaux-Lamy syndrome, commonly referred to as MPS Type VI, when Nicholas was only 3 and his brother 4. ...
- 2theadvocate.com
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Maroteaux-Lamy
you may want to try searching the Internet using the Google search box below.
|
|
|
